Research Analysts Set Expectations for QIPT FY2025 Earnings

Key Points

• Stifel Canada forecasts Quipt Home Medical's FY2025 earnings at ($0.13) per share, which is below the current consensus estimate of ($0.05) per share.
• The company recently reported a quarterly loss of ($0.07) per share, missing expectations by $0.10, with revenues of $58.30 million falling short of estimates of $80.37 million.
• Quipt Home Medical's stock price has experienced fluctuations, currently trading at $2.02, with a market cap of $87.92 million and a 12-month trading range between $1.35 and $3.27.

Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) - Analysts at Stifel Canada issued their FY2025 earnings per share estimates for shares of Quipt Home Medical in a research note issued to investors on Tuesday, August 12th. Stifel Canada analyst J. Keywood anticipates that the company will earn ($0.13) per share for the year. The consensus estimate for Quipt Home Medical's current full-year earnings is ($0.05) per share. Stifel Canada also issued estimates for Quipt Home Medical's Q4 2025 earnings at $0.03 EPS.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last issued its earnings results on Monday, August 11th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.10). The company had revenue of $58.30 million for the quarter, compared to analysts' expectations of $80.37 million. Quipt Home Medical had a negative net margin of 4.30% and a negative return on equity of 9.78%.

A number of other research firms have also recently commented on QIPT. Canaccord Genuity Group raised their target price on Quipt Home Medical from $1.70 to $2.30 and gave the company a "hold" rating in a research note on Tuesday. Wall Street Zen upgraded Quipt Home Medical from a "sell" rating to a "hold" rating in a research note on Saturday. Finally, Benchmark reiterated a "buy" rating and set a $4.00 target price (down from $6.00) on shares of Quipt Home Medical in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $3.15.

Quipt Home Medical Trading Up 3.7%

NASDAQ QIPT traded up $0.08 on Friday, hitting $2.25. The company's stock had a trading volume of 442,399 shares, compared to its average volume of 531,332. Quipt Home Medical has a 52-week low of $1.35 and a 52-week high of $3.27. The company has a current ratio of 1.15, a quick ratio of 0.75 and a debt-to-equity ratio of 0.71. The company's 50-day simple moving average is $2.02 and its 200 day simple moving average is $2.17. The firm has a market cap of $97.75 million, a P/E ratio of -9.37 and a beta of 0.59.

Institutional Investors Weigh In On Quipt Home Medical

Several large investors have recently made changes to their positions in the company. Kanen Wealth Management LLC increased its holdings in shares of Quipt Home Medical by 108.4% in the first quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company's stock worth $6,919,000 after purchasing an additional 1,544,529 shares during the last quarter. First Manhattan CO. LLC. increased its holdings in shares of Quipt Home Medical by 3.1% in the fourth quarter. First Manhattan CO. LLC. now owns 1,650,000 shares of the company's stock worth $5,032,000 after purchasing an additional 50,000 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Quipt Home Medical by 6.5% in the first quarter. Russell Investments Group Ltd. now owns 969,822 shares of the company's stock worth $2,260,000 after purchasing an additional 59,204 shares during the last quarter. Franklin Resources Inc. increased its holdings in shares of Quipt Home Medical by 16.8% in the second quarter. Franklin Resources Inc. now owns 824,124 shares of the company's stock worth $1,475,000 after purchasing an additional 118,332 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of Quipt Home Medical by 9.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 631,112 shares of the company's stock worth $1,130,000 after purchasing an additional 52,195 shares during the last quarter. 42.85% of the stock is owned by institutional investors.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.